Globus Medical GMED Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's accounts receivable, credit loss expense (reversal)?
- Globus Medical (GMED) reported accounts receivable, credit loss expense (reversal) of $5.28M in Q1 2026.
- How has Globus Medical's accounts receivable, credit loss expense (reversal) changed year-over-year?
- Globus Medical's accounts receivable, credit loss expense (reversal) increased by 64.6% year-over-year, from $3.21M to $5.28M.
- What is the long-term trend for Globus Medical's accounts receivable, credit loss expense (reversal)?
- Over 2 years (2021 to 2025), Globus Medical's accounts receivable, credit loss expense (reversal) has grown at a 191.9% compound annual growth rate (CAGR), from $1.2M to $10.22M.